Using an End-of-life Conversation Game to Engage Patients With Cancer in Advance Care Planning
Adapting an Advance Care Planning Intervention and Delivery Model for Use With Patients With Cancer and Their Caregivers
1 other identifier
interventional
14
1 country
1
Brief Summary
The goal of this clinical trial is to explore feasibility, acceptability, and effectiveness of end-of-life conversation game "Hello" as a tool to help individuals with breast, lung, and/or genito-urinary cancers treated at Penn State Cancer Institute and their loved ones perform advance care planning. The main questions it aims to answer are:
- What modifications and/or adaptations are necessary to Hello for use in cancer populations?
- How do different delivery models compare for recruitment in terms of feasibility and efficiency? Participants will:
- Complete pre-game questionnaires
- Play the Hello game
- Complete post-game questionnaires
- Participate in a focus group
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable breast-cancer
Started Oct 2023
Shorter than P25 for not_applicable breast-cancer
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 29, 2023
CompletedFirst Posted
Study publicly available on registry
September 8, 2023
CompletedStudy Start
First participant enrolled
October 31, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 31, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
January 31, 2024
CompletedFebruary 28, 2024
February 1, 2024
3 months
August 29, 2023
February 27, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Experiences and perceptions of intervention
Group discussions held with patients with cancer and their caregivers to collect qualitative data on acceptability of the game, necessary modifications for use in patients with cancer and their caregivers, and other feedback and opinions on the game experience.
Immediately post-intervention
Secondary Outcomes (4)
Advance Care Planning Engagement Measure
Baseline
Advance Care Planning Surrogate Decision Maker Engagement Measure
Baseline
Satisfaction of Intervention Measure
Immediately post-intervention
Acceptability of Intervention Measure
Immediately post-intervention
Study Arms (1)
Game participants
EXPERIMENTALAll participants will engage in playing the end-of-life conversation game called "Hello", which involves answering open-ended questions about medical decision making and end-of-life issues.
Interventions
To play 'Hello', players are provided 32 open-ended questions in a prearranged order and an equal number of game chips. A player reads aloud the first question. Players then individually write down their answers, and take turns sharing answers with the group (players can opt to pass). Players control how long they share, what they share, and when they are ready to proceed to the next question. During the conversation, players may choose to acknowledge others for a particularly thoughtful, poignant, or even funny comment by giving them a chip. A simple pre-game coin flip determines whether the player with the most chips 'wins' the game ('heads'), or the player with the least amount of chips wins the game ('tails'). Other Name: Previously named "My Gift of Grace"
Eligibility Criteria
You may qualify if:
- Adults (\> 18 years old)
- Able to speak and read English
- Be an individual diagnosed with breast, lung, or genitourinary/prostate cancer as verified by primary oncologist or is the chosen caregiver for a participant with those cancers
- Receives care at Penn State Health or is the chosen caregiver for a participant treated at Penn State Health
- Adults (\> 18 years old)
- Able to speak and read English and/or Spanish
- Be the chosen caregiver for a participant with cancer
You may not qualify if:
- Anyone \<18 years of age
- Anyone unable to speak and read English
- Unable to provide informed consent
- Receives cancer care exclusively outside of Penn State Health
- Anyone \<18 years of age
- Anyone unable to speak and read English
- Unable to provide informed consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Penn State Cancer Institute
Hershey, Pennsylvania, 17033, United States
Related Publications (1)
Kimbel K, Hayes M, Bucher M, Calo WA, Garg T, Joshi M, Kuntz H, Murphy TE, VanDyke E, Wasserman E, Van Scoy LJ. Facilitating Advance Care Planning Conversations Among Patients With Cancer and Their Care Partners Utilizing a Conversation Game: A Pilot Study. Cancer Rep (Hoboken). 2025 Jun;8(6):e70250. doi: 10.1002/cnr2.70250.
PMID: 40528532DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Lauren Van Scoy, MD
Penn State College of Medicine
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor of Medicine, Humanities and Public Health Sciences
Study Record Dates
First Submitted
August 29, 2023
First Posted
September 8, 2023
Study Start
October 31, 2023
Primary Completion
January 31, 2024
Study Completion
January 31, 2024
Last Updated
February 28, 2024
Record last verified: 2024-02
Data Sharing
- IPD Sharing
- Will not share